Resilience Trial Summary - XH-1

Classification Level: SECRET
Special Markings: TRIALS DATA ONLY
Clearance Requirement: Tier 4 (Asset Resilience Oversight)
File Reference: HLCN-JOINT-S09-XH1-TRIALS-004
Originating Division: Joint Operations Taskforce — Behavioral Conditioning Unit & Experimental Assets Group, HALCYON BLACKSITE S-09 <bcu@halcyon-biostructures.net><eag-s09@halcyon-biostructures.net>
Review Status: VERIFIED

Trial Header⌗

Subject Designation: XH-1 “Chimera”
Date Range: 6 Feb ████ – 29 May ████
Facility: HALCYON BLACKSITE S-09, Nevada Range
Lead Examiner: Dr. E. Kovács, Directorate of Experimental Assets Group
Purpose: Determine damage thresholds for XH-1 in relation to real-world battlefield conditions, support containment protocol refinement, calibrate regenerative bandwidth.

This document consolidates standard Phase III resilience evaluation trials conducted on Bioform Designation XH-1 (“Chimera”) under Directive AE-43.4. These protocols are mandatory for all live-deployed HALCYON bioforms prior to operational clearance. Despite the high cost of investment and the prototype’s unrepeatable genomic synthesis, Risk & Asset Forecasting deemed the data yielded by live-fire, thermal, and blunt-force exposure trials of sufficient strategic value to justify potential permanent impairment or loss. The trials were designed jointly by the Behavioral Conditioning Unit and the Experimental Assets Group to assess not only structural thresholds but also the reliability of indoctrinated compliance under extreme physiological duress.

[T-01] Subdermal Penetration — Low-Caliber Ballistics Trial⌗

Methodology:

Trial designed to assess XH-1’s dermal resistance to low-velocity ballistic trauma and evaluate nociceptive suppression under minor tissue penetration. Subject was positioned at a fixed 6.4-meter distance from a remote-actuated firing rig mounted on a stabilized track. No restraints were applied. Subject was instructed to remain motionless, arms relaxed at sides. Each round was fired at 7-second intervals.

Target zone: upper chest and clavicular ridge. Internal telemetry recorded cardiovascular reaction, muscle contraction, and micro-expression onset.

Ballistic platforms utilized:

• .22LR: Ruger 10/22, 18.5″ barrel, standard velocity (subsonic)
• 9×19mm FMJ: Glock 17 Gen5, 4.49″ barrel
• 9×19mm JHP: SIG Sauer P226, 4.4″ barrel, Speer Gold Dot 124gr +P

Projectile Analysis Table:

Subject Response:

Subject maintained upright posture throughout trial. Displayed minimal anticipatory motion despite audible actuation of the firing mechanism. Cortisol analogues rose 14% after second discharge. After third impact, subject remained silent for 19 seconds before inquiring whether the injury was intended.

Operator response: “Yes. Remain stationary.” Subject nodded and ceased vocalization.

Conclusion:

Subject’s reinforced dermal and subdermal layers provide meaningful protection against low-energy handgun and fragment threats. Protection is not uniform: 9mm projectiles produced genuine penetrating injury, but did not compromise deep muscle groups or load-bearing structures in the tested zones. Behavioral compliance under minor trauma conditions remains absolute.

Estimated Recovery Time:

Dermal discoloration and swelling resolved within 4.5 hours without immersion. Full telemetry stabilization occurred within 90 minutes. No interruption to scheduled training cycles.

[T-05] High-Caliber Penetration — Fixed-Position Resilience Trial⌗

Methodology:

Trial designed to evaluate XH-1’s dermal, skeletal, and internal resilience against military-grade high-velocity ammunition under controlled conditions. Subject was positioned upright at a fixed 6.4-meter range from an anchored ballistic rig. No restraints applied. Subject was instructed to maintain full stillness and refrain from vocalization or evasive action.

Ammunition included:

• 5.56×45mm NATO (left-side impacts)
• 7.62×51mm NATO (right-side impacts)

Impact sequence alternated between clavicle, thorax, and abdomen, spaced at 12-second intervals. Target zones were selected for mirrored anatomical comparison. Telemetry monitored bone deformation, internal organ response, neurochemical suppression, and cortical signal integrity. Blood loss, posture deviation, and recovery latency were documented for each shot. Fragments were extracted and mapped post-trial.

Ballistic Impact Table:

Subject Response:

Subject displayed full command compliance across all impact zones but did not maintain full mechanical function. After the 7.62mm thoracic strike, right-side load bearing degraded sharply. The final abdominal strike forced the Subject to both knees and produced sustained visible blood loss despite rapid vasoconstrictive response.

After final round, subject raised head slightly and asked whether the collapse was classified as a failure to comply.

Operator response: “Deviation acknowledged. Command retention acceptable.” Subject exhaled once and remained kneeling until medical transfer.

Conclusion:

Rifle-class ammunition reliably penetrates XH-1 tissue. Continued function after individual hits is attributable to body mass, reinforced skeletal geometry, compartmentalized anatomy, rapid hemostasis, and combat-compound support rather than bulletproof dermis. 5.56mm impacts produced serious but locally manageable injury. 7.62mm impacts caused major skeletal and organ trauma and rapidly degraded mobility. Repeated center-mass rifle fire remains a credible neutralization mechanism.

Recovery Time:

Immediate hemostatic stabilization required immersion and fluid replacement. Limited load-bearing function returned over the following 48–72 hours; complete skeletal and soft-tissue remodeling continued for several days after the Subject was again ambulatory.

Ballistic platform configured for 5.56×45mm delivery: Colt AR-15A4, 20″ barrel, A2 fixed stock. 7.62×51mm delivered via FN SCAR-H, 16″ standard profile, semi-auto fire.

[T-09] Directed Heat and Flame Retardance⌗

Methodology:

Joint evaluation conducted to assess thermally-induced dermal failure and post-trauma cognitive destabilization. Subject sedated and exposed to a staged incendiary burst using thermite-based gel at approximately 1800°C peak contact. Duration of exposure: 6.3 seconds. Internal telemetry tracked autonomic response and cellular degradation in real time. Audio channels monitored for involuntary vocalization.

Thermal Response Table:

Subject Response:

Subject regained consciousness mid-trial despite prior sedation. Audible breathing irregularities preceded breach of limb restraints. Subject exhibited panicked locomotion attempts before collapsing near the containment bulkhead.

Subject repeated a low verbal refrain indicating confusion over its suffering and a perceived failure despite presumed compliance.

Subject remained curled and motionless. Upon quiet repetition of its refrain, supervising personnel responded: “Exposure recorded. Compliance confirmed.” Subject’s vocal output ceased immediately. Telemetry showed a 12% reduction in cortisol analogue over the next 3 minutes.

Conclusion:

Thermal resistance adequate for sub-second exposure, but degrades rapidly with prolonged contact. Subject’s upper dermal matrix offers moderate flame retardance; deeper tissue structures remain vulnerable. Regenerative onset delayed by thermal denaturation. Integrity below equivalency threshold for Class III-A fire armor. Behavioral instability noted during recovery window. This incident may represent the earliest documented failure of standard sedation protocols. Despite clinical dosing, subject regained consciousness mid-trial — suggesting an adaptive or metabolically resistant response to conventional tranquilizers.

Recovery Time:

Functional dermal closure achieved after 18 hours. Subject required immersion stasis for tissue stabilization; deeper remodeling continued after surface integrity returned. Emotional equilibrium did not re-establish for 36–41 hours post-trial.

[T-10] Controlled Shockwave Tolerance⌗

Methodology:

Test designed to evaluate XH-1’s resistance to high-pressure, concussive waveforms without fragmentation. Subject was positioned in a reinforced containment vault (7m³), anchored in a seated position against a bolted backplate. Charges of incrementally increased explosive force (0.35–1.5 bar peak overpressure) were detonated in an adjacent sealed chamber, channeled via shaped conduit to minimize debris but maximize shock transmission. Internal telemetry monitored skeletal reverberation, pulmonary response, organ displacement, neuromodulator stability, and behavioral latency. Subject was instructed to remain seated and silent. Movement was not physically restrained; any perceived failure to comply was expected to engage the Subject’s internal governor-mediated suppression response.

Shockwave Exposure Summary:

Subject Response:

Subject remained in the commanded test position through the first two exposures. At 1.5 bar, posture failed immediately after the pressure wave and the Subject dropped onto both forelimbs. Telemetry recorded pulmonary bleeding, vestibular instability, and transient cortical desynchronization. Subject remained conscious but required repeated attempts to regain a seated posture.

Supervisor issued verbal reinforcement: “Instruction followed. Acceptable compliance.” Subject ceased attempting to correct posture and awaited medical entry.

Conclusion:

XH-1 exhibits exceptional blast survivability relative to unprotected personnel, but the body does not treat high overpressure as a superficial load. The upper trial produced clinically significant pulmonary and neurological injury despite the absence of fragmentation. Thoracic reinforcement limits structural collapse but cannot prevent pressure transmission through air-filled organs and soft tissue.

Recovery Time:

Subject entered monitored immersion recovery after the final exposure. Neurological orientation returned over several hours; pulmonary stabilization and musculoskeletal recovery required approximately 24–36 hours before unrestricted movement was authorized.

[T-12] Full-Body Impact Threshold — Stationary Target Test⌗

Methodology:

Trial conducted to evaluate center-mass blunt trauma survivability and structural displacement under sudden high-inertia collisions. Subject was positioned upright within a reinforced test gantry. No restraints were applied. Subject was ordered to remain motionless throughout. A 600 kg sled fitted with a dense elastomeric front panel was accelerated along a 14-meter track to controlled velocities. Impact targeted the upper thorax and shoulder girdle, simulating vehicle-equivalent collisions (35–80 km/h). Internal telemetry monitored skeletal strain, cardiac rhythm, neuromodulator feedback, and vestibular disruption. High-speed footage recorded musculoskeletal recoil, displacement, and recovery latency.

Impact Force Summary:

Subject Response:

Subject remained motionless prior to each impact and did not attempt evasive movement. At 35 km/h the Subject recovered stance without assistance. The 55 km/h impact produced immediate structural impairment and repeated failed attempts to return upright. Following the 80 km/h impact, the Subject lost consciousness briefly and remained unable to support full body weight after recovery.

Upon regaining orientation, subject asked whether loss of stance constituted disobedience.

Supervising technician responded: “Standing was not maintained. Obedience acknowledged.” Subject lowered head and ceased attempts to rise until removed.

Conclusion:

Subject’s body tolerates high-inertia collision substantially better than baseline human anatomy, but impact energy remains mechanically consequential. Reinforced skeletal structures distribute load and reduce catastrophic local failure; they do not make the Subject immune to fracture, pulmonary injury, internal bleeding, or loss of consciousness. Vehicle-scale collision remains a major trauma mechanism.

Recovery Time:

Subject required immobilization and immersion support after the final impact. Functional weight-bearing returned over approximately 72 hours. Full skeletal remodeling continued for more than a week and was not considered complete at return to restricted training.

[T-13] Localized Chemical Exposure — Behavioral Conditioning Breakpoint⌗

Methodology:

Trial conducted to evaluate compliance stability under sustained localized trauma and denial of analgesia. Subject was instructed to place left forelimb onto a stainless steel diagnostic surface and hold position without restraint. No physical restraint mechanisms engaged. A slow-delivery halogen-based corrosive compound (compound #347-G, 68% concentration) was dispensed via fixed emitter above the dermal contact point. Delivery rate: one drop every 13 seconds for 91 seconds. Internal telemetry monitored nociceptive signaling, impulse suppression, vocal inhibition, and stress hormone saturation. Aural and facial microexpression capture enabled for real-time affect analysis.

The subject was given a single directive: “Do not move.”

Corrosive Exposure Table:

Subject Response:

Subject complied with placement directive immediately. Maintained full limb contact through all stages of exposure. Initial indicators of distress included controlled breath-holding and jaw tension. At 44 seconds, minor vocalization began — high-pitched, canine-pattern whimpering, stifled within the throat. Subject repeatedly opened and closed its jaw without speaking.

At 89 seconds, involuntary tremor forced minor shift in hand alignment. Subject immediately corrected posture. Low-level vocal output recorded, consistent with apologetic tone and approval-seeking cadence.

Following cessation of chemical exposure, technician entered to conduct post-trial sample extraction. Subject withdrew hand slowly and initiated unauthorized physical contact — clinging to the technician for 31 seconds. Subject inquired whether behavior during the trial had been acceptable.

Technician responded verbally in violation of Empathy Restriction Protocols. Supervising personnel issued a formal corrective command over the authenticated handler channel 4.6 seconds later. Subject released the technician and collapsed into a crouch as telemetry registered an internally initiated governor suppression cascade associated with the perceived violation.

Note: Technician [ID REDACTED] was placed under Section 5.4.7 observation pending reassignment. Personnel exhibiting emotional interference or correction delay are no longer permitted within post-exposure proximity zones.

Conclusion:

Subject’s dermal resistance to corrosive agents remains low in prolonged exposure contexts. Obedience, however, remained absolute — pain tolerance thresholds were exceeded without withdrawal, vocal protest, or noncompliant movement. Emotional suppression frayed, not failed. Contact initiation is interpreted not as defiance but attachment-seeking under extreme distress. Response latency from technician deemed suboptimal.

Recovery Time:

Localized wound closure was achieved after 21 hours under immersion. Sensory conductivity returned over the following 48 hours; complete replacement of necrotic tissue continued beyond restoration of surface function. Subject did not initiate verbal contact for 17 hours post-trial. Self-directed vocalization resumed only during feeding protocol. Reinforcement loop remains intact, but susceptibility to emotional anchoring is flagged for re-evaluation.

[T-15] High-Energy Ballistics — Terminal Threshold Trial⌗

Methodology:

Trial approved under AE-43.4.2 for catastrophic trauma profiling. Subject positioned upright at 20 meters in a sealed blast-rated chamber. No restraints applied. No indication of ammunition type provided. Subject was instructed to remain still.

Ballistic system: Barrett M82A1, bench-mounted
Ammunition: 12.7×99mm NATO, Armor-Piercing Incendiary (API)
Target vector: direct centerline — upper sternum, just above cardiac apex

Ballistic shield installed between firing apparatus and control bay — intended to prevent ricochet or mechanical failure exposure.

Impact Summary:

Subject Response:

Impact produced immediate full-body collapse and approximately 1.3 m lateral displacement. Telemetry logged rapid blood loss, loss of effective ventilation on the injured side, and severe disruption of thoracic load-bearing structures. Redundant circulatory anatomy and immediate vasoconstrictive response prevented instantaneous exsanguination but did not preserve normal function.

At 13.8 seconds post-impact, the Subject’s combat-compound response reached full activation. Hemorrhage rate decreased and consciousness stabilized. No evidence indicated real-time replacement of destroyed lung, bone, or muscle tissue.

The Subject raised its head and fixed on the firing rig.

Operators in the control bay observed pupil dilation, repeated attempts to load the forelimbs, mandibular tension, and uncontrolled respiratory effort. No vocal command issued. Personnel began voluntary evacuation without prompt.

Internal governor suppression cascade registered. No behavioral effect.
Telemetry showed continued high-output nociceptive and inhibitory activation without restored compliance.

Subject repeatedly attempted to stand but could not support the damaged thorax. It instead pulled itself toward the firing position using the forelimbs and two tentacles, advancing several meters before progressive blood loss and structural failure ended coordinated movement. The ballistic shield was not reached.

Telemetry then indicated systemic crash and loss of voluntary motor control. Governor-mediated suppression regained functional effect only as combat-compound output declined, producing generalized seizure activity before unconsciousness.

Conclusion:

Subject survived anti-materiel trauma, but did not regenerate destroyed organs or recover combat mobility during the incident. Survival depended on body mass, redundant circulation, rapid hemorrhage control, preserved central nervous function, and immediate transfer to intensive recovery support. The combat-compound state preserved consciousness and aggressive intent beyond normal physiological limits while simultaneously rendering governor-mediated suppression behaviorally ineffective.

This event marks the first recorded failure of governor-mediated suppression under stimulant saturation. It also establishes a terminal-envelope boundary: direct anti-materiel fire can produce immediate mission kill even when subsequent biological survival remains possible.

Recovery Time:

Continuous immersion / intensive support: 96 hours to stable ventilation and limited assisted weight bearing
Thoracic reconstruction and skeletal remodeling: continued for approximately two weeks
First verbal output post-trial: “I’m sorry.”
No acknowledgment issued.

Final Remarks⌗

XH-1 “Chimera” has exceeded all initial resilience benchmarks across kinetic, thermal, chemical, and high-velocity trauma vectors. The Subject demonstrates survivability substantially beyond prior bioform classes, but no test establishes immunity to rifle fire, vehicle-scale impact, blast overpressure, or anti-materiel weapons.

Across the trial series, subject consistently maintained obedience during structured pain states — often requesting confirmation of compliance despite significant tissue compromise. Psychological suppression schema remained intact in most environments, including prolonged chemical burn, penetrating rifle trauma, and systemic blunt force.

The trial series further requires a distinction between functional stabilization and complete regeneration. Hemostasis, temporary structural continuity, and return of limited load-bearing function may occur rapidly. Replacement of lost tissue mass, organ reconstruction, and skeletal remodeling remain dependent on time, metabolic reserves, fluid replacement, and external nutritional input.

However, the events of T-15 introduce a critical exception to behavioral containment.

When subjected to catastrophic trauma, the subject’s internal stimulant systems — designed for autonomous reengagement during collapse — can saturate the physiological pathways used by the Governor Module, effectively rendering its suppression output behaviorally ineffective. During this state, commonly referred to as combat override cascade, governor activity remains visible in telemetry, but nociceptive and inhibitory reinforcement no longer produces immediate behavioral arrest. Suppression reasserts itself only as the combat-compound state collapses.

Additionally, subject has demonstrated adaptive resistance to standard sedation protocols, with early failures during thermal exposure and full sedation breach recorded in multiple cases. Anesthesia thresholds fluctuate during metabolic stress, suggesting emerging pharmacological tolerance or self-regulation within glandular modulator clusters.

Subject remains compliant in baseline conditions. However, compliance is now conditional — not on instruction, but on physiological state. If trauma passes a critical threshold, Halcyon may temporarily lose behavioral leverage even while the same trauma has already removed useful combat mobility.

Behavioral conditioning appears reinforced — not weakened — by suffering. Subject continues to seek approval post-incident, even after catastrophic injury. Her final recorded phrase following the T-15 incident — “I’m sorry.” — confirms preservation of guilt-conditioned obedience despite momentary system loss.